| Date Filed | Type | Description |
| 02/10/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/08/2023 |
SC 13G
| LANSDOWNE PARTNERS LLP reports a 5.1% stake in MEMBERSHIP COLLECTIVE GROUP INC. |
| 11/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G
| LANSDOWNE PARTNERS LLP reports a 6.2% stake in SUPERNOVA PARTNERS ACQUISITION COMPANY II, LTD. |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/17/2020 |
SC 13D/A
| LANSDOWNE PARTNERS LLP reports a 4.1% stake in Summit Therapeutics PLC |
| 05/15/2020 |
SC 13D/A
| LANSDOWNE PARTNERS LLP reports a 5.3% stake in Summit Therapeutics PLC |
| 05/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/26/2020 |
SC 13D/A
| LANSDOWNE PARTNERS LLP reports a 6.3% stake in Summit Therapeutics PLC |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2019 |
SC 13G/A
| LANSDOWNE PARTNERS LLP reports a 5.5% stake in MANCHESTER UNITED PLC |
| 01/11/2019 |
SC 13D/A
| LANSDOWNE PARTNERS LLP reports a 13.2% stake in Summit Therapeutics PLC |
| 11/13/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/03/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/13/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/30/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/30/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/13/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 09/20/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/11/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|